Skip to content

A randomized, double-blind trial of oral sucrose and placebo for pain relief in retinopathy of prematurity examination

A randomized, double-blind trial of oral sucrose and placebo for pain relief in retinopathy of prematurity examination

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160603001
Enrollment
40
Registered
2016-06-03
Start date
2016-05-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal pain Retinopathy of prematurity examination N&#45

Interventions

Receiving 24% oral sucrose before ROP exam. All of infants must receive eye drop
1%tropicamide and 2.5% phenylephrine per protocol 1 drop every 15 minutes for 4 doses until ROP exam.They will be monitor for heart rate and oxygen saturation by Masimo SET Radical Signal Extraction P
PASS (Neonatal pain&#44
and sedation scale) by main researcher who is blinding for randomization and allocation. Then 0.2 ml of 24% oral sucrose will be dropped into infants’ into one side of buccal area by syringe in the
and sedation scale) by main researcher who is blinding for randomization and allocation. Then 0.2 ml of sterile water will be dropped into infants’ into one side of buccal area by syringe in their
Active Comparator Other,Placebo Comparator Other
24% oral sucrose,Sterile water

Sponsors

Phramongkutklao College of Medicine
Lead Sponsor
Royal Thai Army Medical Service
Collaborator

Eligibility

Sex/Gender
All
Age
28 Days to 2 Months

Inclusion criteria

Inclusion criteria: 1.Infants with birth weight ≤ 1500 g or 2.Infants with gestational age at birth≤32 weeks or 3.Selected infants with a birth weight between 1500 and 2000 g or gestational age of more than 32 weeks with an unstable clinical course, including those requiring cardiorespiratory support and who are believed by their attending pediatrician or neonatologist to be at high-risk

Exclusion criteria

Exclusion criteria: 1.Infant requiring mechanical ventilation or oxygen supplementation 2.Infants with congenital malformations 3.Infant receiving sedation 4.Infants where consent to participate was not obtained from parents

Design outcomes

Primary

MeasureTime frame
Pain scores by N-PASS (Neonatal pain, agitation, and sedation scale) During first eye ROP examination ( about 2 minutes ) Observation. Pain is scored from 0 to 2 for each behavioral and physiological criteria , then summed

Secondary

MeasureTime frame
ROP staging During ROP exam ( 5 minutes ) Examination and observation,Oxygen saturation before and during ROP examination and its treatment During ROP exam ( 5 minutes ) Observation,Event of apnea and its treatment During ROP exam ( 5 minutes Observation

Countries

Thailand

Contacts

Public ContactNithipun Suksumek

Phramongkutklao College of Medicine

drnithipun@hotmail.com+66863060003

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026